Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

Author： Arase Yasuji   Ikeda Kenji   Suzuki Fumitaka   Suzuki Yoshiyuki   Saitoh Satoshi   Kobayashi Masahiro   Akuta Norio   Someya Takashi   Hosaka Tetsuya   Sezaki Hitomi   Kobayashi Mariko   Kumada Hiromitsu  

Publisher： Springer Publishing Company

ISSN： 0944-1174

Source： Journal of Gastroenterology, Vol.39, Iss.11, 2004-11, pp. : 1090-1094

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C

By Takaki Shintaro   Tsubota Akihito   Hosaka Tetsuya   Akuta Norio   Someya Takashi   Kobayashi Masahiro   Suzuki Fumitaka   Suzuki Yoshiyuki   Saitoh Satoshi   Arase Yasuji   Ikeda Kenji   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 7, 2004-07 ,pp. : 668-673

Springer Publishing Company

Access to resources Recommend Favorite

Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C

By Oze Tsugiko   Hiramatsu Naoki   Kurashige Nao   Tsuda Natsuko   Yakushijin Takayuki   Kanto Tatsuya   Takehara Tetsuo   Kasahara Akinori   Kato Michio   Yoshihara Harumasa   Katayama Kazuhiro   Kubota Shinji   Hijioka Taizo   Ishibashi Kazunobu   Oshita Masahide   Hagiwara Hideki   Haruna Yoshimichi   Mita Eiji   Tamura Shinji   Hayashi Norio  

Journal of Gastroenterology, Vol. 41, Iss. 9, 2006-09 ,pp. : 862-872

Springer Publishing Company

Access to resources Recommend Favorite

Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C

By Hollander Anna   Foster Graham   Weiland Ola  

Scandinavian Journal of Gastroenterology, Vol. 41, Iss. 5, 2006-05 ,pp. : 577-585

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

By Tohra S.  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2449-2455

Springer Publishing Company

Access to resources Recommend Favorite

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis

By Syed Eliya   Rahbin Nogol   Weiland Ola   Carlsson Tony   Oksanen Antti   Birk Markus   Davidsdottir Loa   Hagen Karin   Hultcrantz Rolf   Aleman Soo  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 11, 2008-01 ,pp. : 1378-1386

Informa Healthcare

Access to resources Recommend Favorite